Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Somatic dysfunction is a diagnostic term primarily used in osteopathic medicine to describe the impaired or altered function of the body's skeletal, arthrodial, and myofascial structures, including their associated vascular, lymphatic, and neural elements (StatPearls, 2023). It is not a specific molecule, receptor, or enzyme, but rather a clinical finding identified through a physical examination using the TART mnemonic: Tissue texture changes, Asymmetry, Restriction of motion, and Tenderness (American Osteopathic Association). From a biological perspective, it involves altered neurophysiological signaling and local biomechanical stress, which can lead to localized inflammation or pain (Glossary of Osteopathic Terminology). Management of somatic dysfunction typically involves Osteopathic Manipulative Treatment (OMT), which uses manual techniques to restore normal range of motion and alleviate symptoms. Because it represents a structural and functional state of the musculoskeletal system rather than a discrete biological pathway or protein, there are no pharmacological agents that bind to it as a molecular target. Consequently, it is incorrectly classified if presented as a therapeutic target for drug discovery, as it remains a clinical condition addressed through physical intervention.
Not applicable as this is a clinical diagnosis and musculoskeletal state rather than a molecular target; it is typically treated with manual therapy (OMT) rather than targeted pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Somatic dysfunction.